Amy Abernethy

President of Clinical Research Platforms · Verily (Alphabet) · company speakers →

Amy Abernethy is president of clinical research platforms at Alphabet’s Verily, where she has responsibility for the company’s Baseline program and other initiatives to support clinical trials and real-world evidence studies. Before joining Verily, Abernethy was principal deputy commissioner and acting chief information officer of the U.S. Food & Drug Administration. Prior roles include serving as chief medical officer/chief scientific officer of Flatiron Health and multiple roles at Duke University, where she was professor of medicine.

Is this you? Claim this profile →